Author: Lee, Yong-ho; Kim, Jae Hyeon; Kim, So Ra; Jin, Heung Yong; Rhee, Eun-Jung; Cho, Young Min; Lee, Byung-Wan
Title: Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness Document date: 2016_11_8
ID: 4fwp1dnl_11
Snippet: All continuous variables were expressed as the mean ± standard deviation (SD). The AST, ALT, and TG values were log transformed, because value distributions were skewed. Student's t-tests and Pearson's χ 2 tests were used for continuous and categorical variables, respectively, to evaluate any differences according to lobeglitazone responsiveness. A responder to lobeglitazone was defined as any individual who showed a decrease in CAP after treat.....
Document: All continuous variables were expressed as the mean ± standard deviation (SD). The AST, ALT, and TG values were log transformed, because value distributions were skewed. Student's t-tests and Pearson's χ 2 tests were used for continuous and categorical variables, respectively, to evaluate any differences according to lobeglitazone responsiveness. A responder to lobeglitazone was defined as any individual who showed a decrease in CAP after treatment. Changes in clinico-laboratory parameters, including CAP and HbA1C values, after lobeglitazone treatment were evaluated using a paired t-test. We performed correlation analyses to examine the relationship between changes in CAP values and clinico-laboratory parameters at baseline and after treatment. Multivariate linear regression analysis was performed to assess the association between CAP value changes and various clinico-laboratory parameters. The results are expressed as values of standardized (STD) β-coefficients and P values. A twosided P value < 0.05 was considered significant. All statistical analyses were conducted using SPSS for Windows software (version 20.0; SPSS Inc., Chicago, IL, USA).
Search related documents:
Co phrase search for related documents- β coefficient and Multivariate linear regression: 1, 2
- β coefficient and sd standard deviation: 1
- β coefficient and standard deviation: 1, 2, 3, 4, 5, 6
- β coefficient and statistical analysis: 1, 2, 3, 4, 5
- β coefficient and value distribution: 1
- β coefficient and version Windows software SPSS: 1
- β coefficient and Windows software: 1
- β coefficient and Windows software SPSS: 1
- linear regression and lobeglitazone treatment: 1, 2, 3, 4
- linear regression and log transform: 1
- linear regression and mean sd standard deviation: 1, 2, 3, 4, 5, 6, 7, 8
- linear regression and Multivariate linear regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- linear regression and Multivariate linear regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- statistical analysis and USA IL Chicago SPSS statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- statistical analysis and value change: 1, 2
- statistical analysis and value distribution: 1, 2, 3, 4, 5, 6
- statistical analysis and version Windows software SPSS: 1, 2, 3, 4, 5, 6, 7, 8
- statistical analysis and Windows software: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- statistical analysis and Windows software SPSS: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date